Cardiovascular disease in SARS‐CoV‐2 infection
Abstract Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease. Acute cardiac complications include arrhythmia,...
Main Authors: | Kei Sato, Jane E Sinclair, Habib Sadeghirad, John F Fraser, Kirsty R Short, Arutha Kulasinghe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1343 |
Similar Items
-
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01) -
Research Status of SARS-CoV-2 on Cardiovascular System Injury in Children
by: Yuhai Zhang, et al.
Published: (2021-04-01) -
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01) -
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury
by: Federico Biscetti, et al.
Published: (2020-10-01) -
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
by: Zaigham Abbas Rizvi, et al.
Published: (2022-01-01)